User talk:Theresebuchan

Welcome!

Hello,, and welcome to Wikipedia! Thank you for your contributions. I hope you like the place and decide to stay. Here are some pages that you might find helpful: I hope you enjoy editing here and being a Wikipedian! Please sign your messages on discussion pages using four tildes ( ~ ); this will automatically insert your username and the date. If you need help, check out Questions, ask me on, or ask your question on this page and then place  before the question. Again, welcome! JFW | T@lk  02:13, 20 January 2009 (UTC)
 * The five pillars of Wikipedia
 * Tutorial
 * How to edit a page
 * How to write a great article
 * Manual of Style

CML
Please don't replace the current, referenced text with content that is not supported with proper academic references. In general, there is little point discussing phase II drugs. JFW | T@lk  02:13, 20 January 2009 (UTC)


 * Please do not continue to reinsert the same content without discussion. JFW | T@lk  23:35, 21 January 2009 (UTC)

There is no need to email me if you want to discuss an edit. Your contribution should be sourced to sources that meet the criteria outlined in WP:MEDRS (please read that page first before responding to my message here). I feel that it is fairly pointless discussing drugs that are under development by name. I would support an edit that would state "nilotinib and dasatinib may become ineffective if the T315I mutation arises" provided you can provide a journal source for that. If you also have a source that describes the challenges of developing better tyrosine kinase inhibitors in detail then perhaps that is also worth mentioning. But drug development is a volatile process and numerous compounds never make it into the pharmacy; Wikipedia should not be raising false hopes about their therapeutic potential.

Please contact me on my talkpage if you have any further questions. If you want to discuss the edit itself consider discussing it on Talk:Chronic myelogenous leukemia, although there are not many people watching that page. JFW | T@lk  23:24, 28 January 2009 (UTC)